Famotidine Tablets USP — Class II drug recall D-1056-2017
Terminated recall by Teva Pharmaceuticals USA, reported 2017-08-09, distributed nationwide. Failed Tablet/Capsule Specification; out of specification for tablet weight
| Recall number | D-1056-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2017-07-24 |
| Classified | 2017-08-03 |
| Reported by FDA | 2017-08-09 |
| Terminated | 2018-01-31 |
| Distributed | Nationwide (US) |
| Quantity | 28,188 bottles |
| Reason classes | specification failure |
| NDC | 00172-5728, 00172-5728-60, 00172-5728-70, 00172-5728-80, 00172-5729, 00172-5729-60, 00172-5729-70 |
| Lot numbers | 3429066 |
| Expiration dates | 2018-06 |
Product
Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60
Reason for recall
Failed Tablet/Capsule Specification; out of specification for tablet weight
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1056-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.